98 related articles for article (PubMed ID: 11502870)
1. Identification of the P2Y(12) receptor: a novel member of the P2Y family of receptors activated by extracellular nucleotides.
Nicholas RA
Mol Pharmacol; 2001 Sep; 60(3):416-20. PubMed ID: 11502870
[No Abstract] [Full Text] [Related]
2. Osteoblast responses to nucleotides increase during differentiation.
Orriss IR; Knight GE; Ranasinghe S; Burnstock G; Arnett TR
Bone; 2006 Aug; 39(2):300-9. PubMed ID: 16616882
[TBL] [Abstract][Full Text] [Related]
3. Characterization of contractile P2 receptors in human coronary arteries by use of the stable pyrimidines uridine 5'-O-thiodiphosphate and uridine 5'-O-3-thiotriphosphate.
Malmsjö M; Hou M; Harden TK; Pendergast W; Pantev E; Edvinsson L; Erlinge D
J Pharmacol Exp Ther; 2000 Jun; 293(3):755-60. PubMed ID: 10869373
[TBL] [Abstract][Full Text] [Related]
4. The stable pyrimidines UDPbetaS and UTPgammaS discriminate between contractile cerebrovascular P2 receptors.
Malmsjö M; Hou M; Pendergast W; Erlinge D; Edvinsson L
Eur J Pharmacol; 2003 Jan; 458(3):305-11. PubMed ID: 12504787
[TBL] [Abstract][Full Text] [Related]
5. A novel G protein-coupled P2 purinoceptor (P2Y3) activated preferentially by nucleoside diphosphates.
Webb TE; Henderson D; King BF; Wang S; Simon J; Bateson AN; Burnstock G; Barnard EA
Mol Pharmacol; 1996 Aug; 50(2):258-65. PubMed ID: 8700132
[TBL] [Abstract][Full Text] [Related]
6. Nerve growth factor-stimulated neuronal differentiation induces changes in P2 receptor expression and nucleotide-stimulated catecholamine release.
Arthur DB; Taupenot L; Insel PA
J Neurochem; 2007 Mar; 100(5):1257-64. PubMed ID: 17241236
[TBL] [Abstract][Full Text] [Related]
7. Hypotensive effect of UDP on intraocular pressure in rabbits.
Markovskaya A; Crooke A; Guzmán-Aranguez AI; Peral A; Ziganshin AU; Pintor J
Eur J Pharmacol; 2008 Jan; 579(1-3):93-7. PubMed ID: 18031728
[TBL] [Abstract][Full Text] [Related]
8. P2Y receptors regulate proliferation of human pancreatic duct epithelial cells.
Ko T; An HJ; Ji YG; Kim OJ; Lee DH
Pancreas; 2012 Jul; 41(5):797-803. PubMed ID: 22249129
[TBL] [Abstract][Full Text] [Related]
9. P2 purinergic receptors of human eosinophils: characterization and coupling to oxygen radical production.
Ferrari D; Idzko M; Dichmann S; Purlis D; Virchow C; Norgauer J; Chiozzi P; Di Virgilio F; Luttmann W
FEBS Lett; 2000 Dec; 486(3):217-24. PubMed ID: 11119707
[TBL] [Abstract][Full Text] [Related]
10. Expression of P2Y nucleotide receptors and ectonucleotidases in quiescent and activated rat hepatic stellate cells.
Dranoff JA; Ogawa M; Kruglov EA; Gaça MD; Sévigny J; Robson SC; Wells RG
Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G417-24. PubMed ID: 14764443
[TBL] [Abstract][Full Text] [Related]
11. CysLT1 receptor is a target for extracellular nucleotide-induced heterologous desensitization: a possible feedback mechanism in inflammation.
Capra V; Ravasi S; Accomazzo MR; Citro S; Grimoldi M; Abbracchio MP; Rovati GE
J Cell Sci; 2005 Dec; 118(Pt 23):5625-36. PubMed ID: 16306225
[TBL] [Abstract][Full Text] [Related]
12. Selective stimulation of catecholamine release from bovine adrenal chromaffin cells by an ionotropic purinergic receptor sensitive to 2-methylthio ATP.
Tomé AR; Castro E; Santos RM; Rosário LM
BMC Neurosci; 2007 Jun; 8():41. PubMed ID: 17584495
[TBL] [Abstract][Full Text] [Related]
13. Analgesic effects of intrathecal administration of P2Y nucleotide receptor agonists UTP and UDP in normal and neuropathic pain model rats.
Okada M; Nakagawa T; Minami M; Satoh M
J Pharmacol Exp Ther; 2002 Oct; 303(1):66-73. PubMed ID: 12235234
[TBL] [Abstract][Full Text] [Related]
14. Distinct P2Y receptor subtypes regulate calcium signaling in human retinal pigment epithelial cells.
Tovell VE; Sanderson J
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):350-7. PubMed ID: 18172112
[TBL] [Abstract][Full Text] [Related]
15. Extracellular nucleotides and interleukin-8 production by ARPE cells: potential role of danger signals in blood-retinal barrier activation.
Relvas LJ; Bouffioux C; Marcet B; Communi D; Makhoul M; Horckmans M; Blero D; Bruyns C; Caspers L; Boeynaems JM; Willermain F
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1241-6. PubMed ID: 19029040
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules.
Lazarowski ER; Boucher RC; Harden TK
Mol Pharmacol; 2003 Oct; 64(4):785-95. PubMed ID: 14500734
[No Abstract] [Full Text] [Related]
17. ATP and UTP at low concentrations strongly inhibit bone formation by osteoblasts: a novel role for the P2Y2 receptor in bone remodeling.
Hoebertz A; Mahendran S; Burnstock G; Arnett TR
J Cell Biochem; 2002; 86(3):413-9. PubMed ID: 12210747
[TBL] [Abstract][Full Text] [Related]
18. New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2.
Baraldi PG; Romagnoli R; Tabrizi MA; Bovero A; Preti D; Fruttarolo F; Moorman AR; Borea PA
Farmaco; 2005 Mar; 60(3):185-202. PubMed ID: 15784237
[TBL] [Abstract][Full Text] [Related]
19. Functional distribution of Ca2+-coupled P2 purinergic receptors among adrenergic and noradrenergic bovine adrenal chromaffin cells.
Tomé AR; Castro E; Santos RM; Rosário LM
BMC Neurosci; 2007 Jun; 8():39. PubMed ID: 17570839
[TBL] [Abstract][Full Text] [Related]
20. Expression of P2y and P2x receptors in cultured human microglia.
Wang X; Franciosi S; Bae JH; Kim SU; McLarnon JG
Proc West Pharmacol Soc; 1999; 42():79-81. PubMed ID: 10697697
[No Abstract] [Full Text] [Related]
[Next] [New Search]
